EMulate Therapeutics
PrivateLast Round
Crowdfunding
Oct 28, 2025
Est. Valuation
$250M
Total Funding Raised
$733,267
Momentum
Top 50%
of companies Caplight tracks
Company Overview
EMulate Therapeutics is a healthcare company that has developed a platform using ultra-low radio frequency energy (ulRFE®) intended to provide therapeutic benefits for conditions such as cancer, pain, and mental health disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EMulate Therapeutics Comparables
Compare EMulate Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Autem Therapeutics | 85% | |
| Novocure | 77% | |
| TheraBionic | 76% | |
EMulate Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 28, 2025 | ||||
| IPO | Jul 31, 2024 | ||||
| Convertible Debt | Jul 20, 2021 | ||||
| Convertible Debt | Feb 23, 2021 | ||||
| VC Round | Feb 24, 2017 | ||||
Series A Extension | Feb 1, 2012 |
EMulate Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| E.F. Hutton & Co. | IPO |
| Brookline Capital Markets | IPO |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 65% MoM.
- Oct 28, 2025
$103K raised via Wefunder
EMulate Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EMulate Therapeutics's valuation, stock price, and market status.